More Algorae Pharmaceuticals Limited news
Algorae Pharmaceuticals LimitedASX: 1AI

Annual Report and Appendix 4E

Aug 28, 2025 at 7:41 AM EDT · Issued by Algorae Pharmaceuticals Limited

Filed with ASX · Aug 28, 2025 at 7:41 AM EDT

On 6ix: 6ix.com/news/annual-report-and-appendix-4e-6

Algorae Pharmaceuticals Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Algorae Pharmaceuticals Limited on 6ix

Story so far

  • Half Yearly Report Announcement and Appendix 4DFeb 26, 2025
  • Quarterly Activities Report/Appendix 4C Cash Flow StatementJan 30, 2024
  • Quarterly Activities/Appendix 5B Cash Flow ReportOct 27, 2023

Earlier from Algorae Pharmaceuticals

  • Algorae Receives A$318,771 R&D Cash Rebate from ATOJun 5, 2025
  • Peter Mac Partners with Algorae on AI Drug TargetsMay 7, 2025
  • Algorae Receives A$451,359 R&D Cash Rebate from ATOMar 30, 2025
  • Half Yearly Report Announcement and Appendix 4DFeb 26, 2025
  • Significant Cardioprotection Qualities in AI-168 StudiesNov 28, 2024

Later from Algorae Pharmaceuticals

  • Algorae Signs Exclusive License Agreement with SakarSep 22, 2025
  • Algorae Signs Binding Term Sheet with Cadila PharmaceuticalsOct 19, 2025
  • AlgoraeOS Version 2 AI Platform LaunchedNov 9, 2025
  • Prospectus - Loyalty Options OfferNov 16, 2025
  • Loyalty Options OfferNov 16, 2025
All Algorae Pharmaceuticals news releases↗

Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.

Follow Algorae Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer